Tevogen Bio Holdings Inc (NASDAQ:TVGN) shares, rose in value on Friday, June 20, without any change to the previous day’s close as strong demand from buyers drove the stock to $1.20.
Actively observing the price movement in the last trading, the stock closed the session at $1.20, falling within a range of $1.19 and $1.24. The value of beta (5-year monthly) was -0.671. Referring to stock’s 52-week performance, its high was $3.09, and the low was $0.26. On the whole, TVGN has fluctuated by 3.45% over the past month.
With the market capitalization of Tevogen Bio Holdings Inc currently standing at about $220.67 million, investors are eagerly awaiting this quarter’s results, scheduled for in July.
Technical indicators serve as essential tools for traders, offering insights into market sentiment and potential price movements. We see that TVGN’s technical picture suggests that short-term indicators denote the stock is a 50% Buy on average. However, medium-term indicators have put the stock in the category of 50% Sell while long-term indicators on average have been pointing out that it is a Hold.
The stock’s technical analysis shows that the price of TVGN currently trading nearly -6.10% and 4.71% away from the simple moving averages for 20 and 50 days respectively. The Relative Strength Index (RSI, 14) currently indicates a reading of 48.03, while the 7-day volatility ratio is showing 2.70% which for the 30-day chart, stands at 7.62%. Furthermore, Tevogen Bio Holdings Inc (TVGN)’s beta value is -0.68, and its average true range (ATR) is 0.10.
A comparison of Tevogen Bio Holdings Inc (TVGN) with its peers suggests the former has fared considerably weaker in the market. TVGN showed an intraday change of 0.00% in last session, and over the past year, it grew by 37.93%%.
Data on historical trading for Tevogen Bio Holdings Inc (NASDAQ:TVGN) indicates that the trading volumes over the past 10 days have averaged 0.91 and over the past 3 months, they’ve averaged 945.60K. According to company’s latest data on outstanding shares, there are 183.89 million shares outstanding.
Nearly 76.98% of Tevogen Bio Holdings Inc’s shares belong to company insiders and institutional investors own 2.10% of the company’s shares. The data on short interest also indicates that stock shorts accounted for 1.8 million shares as on 2025-05-30, resulting in a short ratio of 2.27. According to the data, the short interest in Tevogen Bio Holdings Inc (TVGN) stood at 366.00 of shares outstanding as of 2025-05-30; the number of short shares registered in 2025-04-30 reached 3.22 million. The stock has risen by 16.50% since the beginning of the year, thereby showing the potential of a further growth. This could raise investors’ confidence to be optimistic about the TVGN stock heading into the next quarter.
